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Abstract 
In this work, the interaction of six natural benzo[c]phenanthridine alkaloids (macarpine, sanguilutine, sanguirubine, 
chelerythrine, sanguinarine and chelirubine) with parallel and antiparallel G-quadruplex DNA structures was studied. 
HT22 corresponding to the end of human telomere and the modified promoter oncogenes c-kit21 and Pu22 
sequences have been used. Spectroscopically-monitored melting experiments and fluorescence titrations, 
competitive dialysis and nuclear magnetic resonance spectroscopy were used with this purpose. The results showed 
that these alkaloids stabilized G-quadruplex structures in terms of increments of Tm values (from 15 to 25 oC) with 
high selectivity over duplexes and unfolded DNA. The mode of binding was mainly by stacking on the terminal G-
tetrads with stoichiometries 1:2 (DNA:ligand). The presence of non-specific electrostatics interaction was also 








Quaternary benzo[c]phenanthridine alkaloids (QBAs) belong to the group of isoquinoline alkaloids. QBAs are present 
in plants from families Fumariaceae, Papaveraceae, Ranunculaceae and Rutaceae. In addition to relatively common 
alkaloids such as sanguinarine and chelerythrine, other less common alkaloids such as sanguilutine, macarpine, 
sanguirubine or chelirubine have been extracted (Figure 1 and S1)1. Some of these have proven antiproliferative 
effects on skin melanoma cells.2 Chelerythrine and sanguinarine, as they are commercially available, have been 
investigated worldwide and their ability to inhibit some important enzymes in cancer cell division has been 
demonstrated many times.3-5 Macarpine, which is found in plants in very small amounts, was first artificially 
prepared by T. Ishikawa6. This alkaloid and its derivatives also show strong cytotoxic effects in cancer cells.7 In the 
case of chelirubine and sanguirubine, antimicrobial, anti-parasitic and anticancer effects have been demonstrated.8, 9 
Besides these various biological effects on cells2, 10, QBA's in their iminium form were reported to interact with 
double stranded DNA (dsDNA) with a relatively weak mode1, 11 and comparable to that of ethidium bromide12. This 
interaction leads to changes in their fluorescent properties. Because of these changes, QBAs could also be used as 
fluorescent DNA probes. 
Other DNA secondary structures have gained interest in recent years. One of these structures is the G-quadruplex 
(GQ) which is present in several protooncogenic-DNA promoters and thus participates in biological processes such as 
replication, transcription and translation13, 14. The building blocks of these structures are the G-tetrads: almost planar 
arrangements of four guanine bases bonded by eight Hoogsteen hydrogen bonds (Figure 1). The G-quadruplex 
structure can be formed by the intermolecular association of four DNA molecules, by the dimerization of two 
molecules that contain two G-tracts, or by the intramolecular folding of a single molecule that contains four G-tracts. 
The topology of G-quadruplexes may be parallel, antiparallel or hybrid, depending on the spatial orientation of the 
four G-tracts. 
A great interest is observed in the potential of G-quadruplex as anticancer target 15 being the enzymatic activity 
inhibited by small ligands which stabilize the G-quadruplex.16 In this work, the ability of natural alkaloids to stabilize 
GQ structures has been studied considering several relevant DNA sequences that have been shown previously to 
form antiparallel and parallel GQ structures (Table 1).  
The HT22 sequence, 5’-A(G3T2A)3G3-3’, corresponds to the end of the human telomere and may adopt different G-
quadruplex structures depending on the environmental conditions. To date, at least five distinct intramolecular G-
quadruplex folding topologies have been reported for natural human telomeric repeats17, 18, four of which were 
observed in the presence of K+ ions19. The crystal structure of this sequence in the presence of K+ formed a parallel 
intramolecular G-quadruplex20. Subsequent studies suggested that the intramolecular G-quadruplex structure 
observed in the K+-containing crystal appears unlikely to be the major form in K+-containing solution. Later, studies 
have shown that the telomeric sequence can form a mixed (3 parallel + 1 antiparallel) structure in K+ solution21. More 
recently, another form was observed in K+ solution, consisting of a two-G-tetrad basket-type core with extensive 
base stacking interactions in the loops17. Finally, an antiparallel (2+2) structure has been observed in Na+ solution22. 
Several GQ-forming sequences have been identified within the promoter segment of the human c-kit oncogene 
upstream of its transcription initiation site. The 21-mer sequence (5’-CG3CG3CGCGAG3AG4-3’, ckit21) forms 
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polymorphic G-quadruplex structures.23-25 but the mutated sequences (c-kit21T21, Table 1), 5’-
CG3CG3CGCGAG3AG3T-3’, and c-kit21T12T21, with one G to T mutation at level of 21 and with two G to T mutations 
at level of 12 and 21 residues, respectively, display more simple conformations. The G21T mutation restrains the 
length of the third loop to a single nucleotide and the fourth G-tract to three guanines. This modification has a 
significant effect on the biophysical properties, leading to the stabilization of the parallel-stranded topology.26, 27 The 
first sequence was used in the present work for CD and fluorescence experiments, the second one for nuclear 
magnetic resonance (NMR) spectroscopy.  
Another important oncogene is c-myc, the overexpression of which is the cause of a wide range of genetic tumors. 
Pu22 is a 22-mer sequence mainly responsible for the c-myc transcriptional activity16. Pu22-14T23T is the same 
sequence with two G to T mutations at position 14 and 23. It adopts the single predominant intramolecular parallel 
GQ conformation under K+ physiological concentration, and thus shows better resolved NMR spectra. Recently, it has 
been reported that Pu22-14T23T gives the same interactions with ligands as wild type Pu22.28, 29 
In this work, the interaction of six natural benzo[c]phenanthridine alkaloids (macarpine, sanguilutine, sanguirubine, 
chelerythrine, sanguinarine and chelirubine) with GQ DNA structures formed by HT22, c-kit21T21, c-kit21T12T21 and 
Pu22T14T23 sequences was studied. Circular dichroism, spectroscopically-monitored melting experiments and 
fluorescence titrations, competitive dialysis and nuclear magnetic resonance spectroscopy were used with this 
purpose.  
Materials and Methods 
Chemicals 
Alkaloids were extracted from plant material in Department of Biochemistry, Faculty of Science, Masaryk University 
(Brno, Czech Rep.). Some of the oligonucleotides used in this work (Table 1) were purchased as dry samples from 
Thermo Fisher Scientific (USA) at HPLC grade. In other cases, DNA synthesis was performed on an Applied 
Biosystems DNA/RNA 3400 synthesizer by solid-phase 2-cyanoethylphosphoroamidite chemistry. DNAs were 
desalted in a Sephadex (NAP-10) G25 column and passed through a DOWEX(Na+) resin to exchange ammonium to 
sodium cations. In all cases, DNAs were diluted in re-distilled water with Trizma® base (10 mM) and EDTA (0.1 mM) 
buffer (pH = 8) to stabilize them during storage. Other chemicals such Trizma® base (C4H11NO3, p.a.) and EDTA (p.a.) 
were obtained from Sigma-Aldrich (USA). Basic chemicals such as KH2PO4, KCl, NaOH and KOH (all p.a. grade) were 
purchased from Lach-Ner (Czech Rep.). 
Instruments 
Absorbance spectra were recorded on an Agilent 8453 diode array spectrophotometer (Agilent Technologies; 
Waldbronn, Germany). Temperature was controlled by means of an Agilent 89090A Peltier device (Agilent 
Technologies). CD spectra were recorded on a Jasco J-810 spectropolarimeter equipped with a JULABO F-25-HD 
temperature control unit (Seelbach, Alemania). Fluorescence spectra were measured with an Aminco-Bowman 
Series 2 spectrofluorimeter (Thermo-Spectronic, USA), equipped with xenon lamp. Temperature was controlled by 
means of a water bath. Excitation wavelength was depending on QBA used for titration, ranging from 330 to 350 nm. 
Emission wavelength for complex QBA:DNA was set to 600 nm. In all spectroscopic studies, Hellma quartz cells (10 
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mm path length, and 350, 1500 or 3000 µl volume) were used. The NMR spectra were recorded on a Bruker AV600 
spectrometer operating at a frequency of 600.10 MHz, equipped with a 5 mm TXI inverse probe and z -axis 
gradients. The 1H spectra were referenced to external DSS (2,2-dimethyl-2-silapentane-5-sulfonate sodium salt) set 
at 0.00 ppm. 
Melting experiments 
In a typical melting experiment, DNA (final concentration 2 µM) was mixed with QBA (4 µM) together with 
phosphate buffer (10 mM) and KCl (5 mM). The concentration of KCl was set to 5 mM instead of the most usual 100 
or 150 mM concentration in order to reduce the high thermal stability of GQ structures. In this way, the potential 
stabilization of the GQ by the presence of QBA in terms of Tm could be determined accurately. The sample was 
heated (96°C) and then allowed to cool slowly. After several hours, the sample was placed to the instrument (Agilent 
8453 UV-Vis or Jasco J815 CD spectrometers). Stirred sample was heated to 96°C and cooled down during 
measurement at a rate of 0.5°C·min-1. Sample was measured also during heating process starting from 20 °C to 96 °C 
in the same rate. The absence of hysteresis was checked for some of the QBA:DNA mixtures. Melting temperatures 
(Tm) were determined as described elsewhere30 using home-made routines written in Matlab® code. 
Fluorescence experiments 
Fluorescence measurements were performed to determine binding stochiometries and overall association constants 
according to equation 1: 
𝐷𝑁𝐴 + 𝑛𝐿𝑖𝑔𝑎𝑛𝑑 ⇌ 𝐷𝑁𝐴 · 𝑙𝑖𝑔𝑎𝑛𝑑𝑛    𝛽 =  
[𝐷𝑁𝐴·𝑙𝑖𝑔𝑎𝑛𝑑𝑛]
[𝐷𝑁𝐴]·[𝑙𝑖𝑔𝑎𝑛𝑑]𝑛
 Equation 1 
The constants were determined from fluorescence-monitored titrations of QBAs by GQ at 25oC. In all experiments, 
the concentration of QBA was kept constant (3 M) whereas the concentration of the considered GQ was increased.  
Binding data analysis was done with the OPIUM program.31  
Alternatively, the Job method was used to determine the binding stoichiometry of the QBA:GQ interaction complex. 
In this method, the total molar concentration of the two molecules was kept constant, whereas the molar fraction 
was varied. The total concentration of QBA and GQ was 3 µM. The stoichiometry of the QBA:DNA interaction 
complex was estimated from the intersection of two lines fitting those points measured at lowest and highest molar 
fractions. 
Competitive dialysis studies  
A 100 l of a 50 M DNA of the different DNA sequences were dissolved in potassium phosphate buffer (185 mM 
NaCl, 185 mM KCl, 2 mM NaH2PO4, 1 mM Na2EDTA, 6 mM Na2HPO4 at pH 7 and introduced into a separated dialysis 
unit (Slide-A-Lyzer™ MINI device, 3500MWCO, Thermo Fisher) and a blank sample containing only buffer. All dialysis 
units were allowed to equilibrate during 24 h at room temperature in a beaker containing the 1 M solution of the 
appropriate QBA. At the end of the dialysis experiment, the amount of QBA bound to the DNA was quantified by 
measuring the fluorescence spectra.  
Nuclear Magnetic Resonance  
The NMR samples of Pu22-T14T23 and c-kit21T12T21 (Table 1) were prepared at concentration 0.34 mM and 0.42 
mM. Pu22-T14T23 was dissolved in 25 mM KH2PO4, 70 mM KCl, pH 6.9 and ckit21T12T21 was dissolved in 5mM 
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KH2PO4, 20 mM KCl, pH 6.9. In these salts condition ckit21T12T21 is present as a monomeric form (Form I).25 The 
DNA samples were heated to 85°C for 1 min and then cooled at room temperature overnight. Stock solution of QBAs 
were prepared in DMSO-d6 because the sanguilutine was poorly soluble in water. 
1H NMR titrations were performed at 25°C by adding increasing amounts of the QBA to the DNA at different ratio 
R=[QBA]/[DNA] and by adding the DNA to a QBA solution in the same experimental conditions.  
The NRM signals of the protons in the complexes were assigned by using NOESY and TOCSY experiments. Phase 
sensitive NOESY spectra were acquired at 25 °C and 35 °C. The best results were obtained at 25 °C, in TPPI mode, 
with 2048 x 1024 complex FIDs. Mixing times ranged from 100 ms to 300 ms. TOCSY spectra were acquired with the 
use of a MLEV-17 spin-lock pulse (60 ms total duration). All spectra were transformed and weighted with a 90° 
shifted sine-bell squared function to 4K x 4K real data points. Proton resonance assignments of GG21-T12T21 and 
Pu22-T14T23 free and complexed were performed on the basis of previous assignments.25, 32, 33 The chemical shift 
values of the complex of chelerythrine with ckit21T12T21 are reported in Table 2. The chemical shift values of the 
complexes of Pu22-T14T23 with sanguilutine and chelerythrine are reported in Table S1 and Table S2 respectively. 
The assignment of the resonances of chelerythrine in the complexes are reported in Tables S3. Some aromatic 
protons of chelerythrine and sanguilutine lie in a crowded region of the oligonucleotide signals and thus could not be 
assigned. Pseudo two-dimensional DOSY experiments were acquired using the pulse-program “stebpgp1s”, diffusion 
delay: 0.24–0.36 s; gradient pulse: 1.5 ms; number of increments: 64. Raw data were processed using the standard 
DOSY software present in the Bruker library (TOPSPIN v. 1.3). 
Results and discussion 
Effect of QBAs on G-quadruplex structure by CD and fluorescence experiments 
First, the overall GQ structures formed by the HT22 and ckit21T21 sequences at the experimental conditions were 
identified by means of CD spectroscopy (Figure S2). The shape and position of the bands in the CD spectra reflected 
the overall antiparallel or parallel nature of the GQ structure. Hence, a positive band around 285 nm indicated the 
predominance of the antiparallel structure in the case of HT22 sequence, and a negative band around 240 nm were 
indications of a parallel structure in the case of the ckit21T21 sequence. In general, the addition of QBA to both HT 
and ckit21T21 GQ structures did not affect dramatically to the shape and intensity of the CD spectra of DNA 
recorded in the UV region (Figure S2). This fact was related to the maintenance of the overall GQ structure upon 
interaction with the ligand. On the other hand, CD measurements in the visible region (Figure S3) did not show the 
appearance of any significant signal related to induced CD (ICD) in the ligand. It is known that strong ICD signals are 
usually related to intercalation34. Therefore, the absence of ICD points out to another binding mode, such as end-
stacking or electrostatics. The absence of intercalation, on the other hand, would agree with the fact that the overall 
GQ structure is maintained because this mode of interaction probably would alter the DNA structure. 
Thermal stabilization 
Melting experiments were carried out to observe any positive contribution of QBAs to the thermal stability of GQ 
structures. It is known that a shift in the unfolding process of GQ in presence of a ligand towards higher temperature 
values reflects the tendency of the ligand to interact more strongly with the GQ folded species than with the 
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unfolded strand35. Table 3 summarizes the determined melting temperature (Tm) values in the absence and presence 
of QBAs. 
The melting experiments with antiparallel structure HT22 were monitored either with UV-Vis or CD spectroscopies. 
The determined Tm values in both cases were very similar (within ±0.5°C). Melting temperature of HT22 was found to 
be 51.0°C (Figure 2). Practically no changes between melting temperatures calculated from data obtained during 
cooling or heating the studied systems were observed (Figure S4), which ruled out the presence of hysteresis. In 
general, all other QBAs produced a clear stabilization of this GQ structure. The highest Tm value in case of HT22 was 
observed for sanguinarine (ΔTm = 18.1 °C), which reflects a greater tendency of this ligand to interact with the folded 
GQ structure than with the unfolded strand. On the other hand, macarpine (ΔTm = -0.9 °C) showed a similar tendency 
to interact with both species (GQ folded and unfolded strand). 
Melting experiments on parallel structure ckit21T21 were exclusively made by CD spectrometry because of the low 
absorbance changes observed at 295 nm during measurements (see an example in Figure S5). The Tm value of 
ckit21T21 was found to be 50.0°C. In this case, the most conspicuous shifts in case of ckit21T21 were observed for 
chelirubine (Tm = 24.5 °C) and sanguilutine (Tm = 22.4 °C). Again, macarpine showed the lowest GQ-stabilization 
properties, as Tm only increased 6.3 °C. To our knowledge, the stabilizing propierties showed by chelirubine is one of 
the highest observed differences in melting values for parallel GQ structures.33, 36, 37 As example, the model ligand 
TMPyP4 stabilizes telomeric DNA less than selected alkaloids about (ΔTm = 1 – 13°C) at the same concentration 
ratio.37-39 
In general, the studied alkaloids show Tm values higher in the case of parallel GQ (ckit21T21) than in the case of 
antiparallel (HT22) structures. This fact may be related to the different loop geometry in both structures, as the GQ 
core formed by three G-tetrads is similar. It seems that these alkaloids interact much better with a structure showing 
double-chain reversal loops, like ckit21T21. 
For a given GQ structure, the determined Tm values may be qualitatively correlated with the presence and nature of 
substituents in the benzo[c]phenanthridine skeleton of the considered QBAs (Figures 1 and S1). For HT22, the ligands 
that shift the most the Tm value of the GQ structure were those showing an –H atom at R5 position, and –O-CH2-O- 
group between R1 and R2. Sanguinarine and and chelirubine (the most stabilizing ligands) have also lower value of 
pKR+ in comparison to other alkaloids (8.05 and 7.7 respectively)40. The substitution on R4, R6, or R3 does not have 
any significant influence on ΔTm. For ckit21T21, the ligands showing significant Tm values are those having an –H 
atom at R6, and no –OCH2-O– group between R3 and R4. 
The weaker stabilization induced by macarpine in both GQ structures could be due to steric effects related with the 
additional –O-CH3 group at position R6 (Figures 1 and S1). All the other alkaloids, which do not include R6 group, 
showed GQ-stabilizing properties.  
Selectivity 
At this point, it is necessary to mention that melting experiments with dsDNAs and QBAs did not show any significant 
increase of melting temperature (Tm < 2°C) (Figure 2b). Therefore, QBAs appeared as a potential selective group of 
ligands to bind GQ structures. To gain more information about the selectivity of QBAs for DNA structures or 
sequences, competitive dialysis experiments were performed (Figure 3 and Table S4)41. In these, a set of dialysis 
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units containing different DNA sequences, some of them prone to form folded structures, is placed inside a solution 
of the considered ligand. After an equilibration period, part of the ligand enters to the dialysis units depending on its 
selectivity towards each sequence or structure, as well on the binding stoichiometry. Quantification is done by 
measuring emission fluorescence at 600 nm. In this work, a set of different DNA sequences (Table 1) representing 
several nucleic acid structures was used.16, 25, 28, 42 T20 was used as model for an unfolded single-stranded DNA 
sequence. As models of dsDNA, the self-complementary sequences Dickerson-Drew dodecamer and a 26-mer 
hairpin (ds26) were used. 
It was observed that the measured fluorescence in tubes containing DNA sequences was much higher than that 
measured for the blank. Therefore, it was clear that all ligands showed a strong tendency to interact with the stable 
DNA structures formed by the considered sequences at 20 oC, approximately. It is difficult to extract quantitative 
information from this experiment as ligands show slightly different values of quantum yields. Moreover, the binding 
stoichiometry may be different among DNA sequences, affecting to the measured fluorescence. However, some 
information may be extracted. First, all alkaloids show low tendency to interact with T20 sequence, which forms a 
rather unfolded species at these conditions. Second, even though double stranded structures formed by ds26 and 
Dickerson show more binding sites than compact GQ structures, the fluorescence intensity is higher for GQ 
structures, such as HT22, ckit21T21 or bcl-2. This fact was clear in the cases of sanguinarine (SG) or chelerythrine 
(CHE). Finally, for some alkaloids, such as chelerytrhine or sanguilutine (SL), which show a binding stoichiometry 1:3 
for both HT22 and ckit21T21 GQ structures (see below), the fluorescence intensity is higher for the parallel structure 
than for the antiparallel one. 
Determination of DNA:ligand stoichiometry 
The interaction of GQ with the QBAs causes an increase of their intrinsic fluorescence that can be used to determine 
stoichiometries and to calculate binding constants (Figure 4) by means of mole-ratio experiments. In these, the 
concentration of QBA was kept constant (3 M) whereas the concentration of the considered GQ was increased 
along the experiment. At the temperature of the experiment, 25oC, GQ structures are completely folded as the 
corresponding Tm values are higher than 50 oC. On the other hand, the emission was measured in a region (500 – 600 
nm) where the potential inner effect filter due to absorption of the titrant (around 260- 300 nm) cannot be 
produced. 
Figure 4a shows the titration of MA with HT22. The titration curve showed the typical sharp initial slope of intensity 
with increase of GQ concentration indicating a strong interaction. At higher concentration of GQ, instead of the 
expected constant fluorescence intensity, the signal was continuously increasing. The continuous increase of 
fluorescence intensity could be caused by the intrinsic fluorescence of DNA bases or by non-specific interaction 
between DNA and alkaloid1. To remove this effect from the overall titration curve, the dependence of the 
fluorescence of macarpine with the unfolded oligonucleotide (A)12 concentration was measured (bottom curve). The 
contribution of this fluorescence signal was removed before the calculation of constants, yielding the curve with flat 
top shown in Figure 4b. From titration curves binding stoichiometry and stability constants were estimated (Table 3). 
Best fitting models were found to have (GQ:QBA) stoichiometry 1:3 or 1:4. Additional experiments based on Job’s 
method provided similar values of stoichiometry (selected examples are shown in Figure S6).  
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The 1:3 stoichiometry was the best fit for both studied GQ structures with almost all alkaloids. At neutral pH QBAs 
are mostly in iminium (positively charged) form as their pKR+ values lie between 7.7 and 943. As previously reported, 
QBAs in iminium form interact with dsDNA forming highly luminescent complexes.44 Although there is no clear 
evidence for the mechanism of interaction with dsDNA, it is supposed that planar positively charged alkaloids are 
intercalated between base pairs of DNA and due to this incorporation, the luminescence is enhanced (except for 
sanguinarine). A similar enhancement of the luminescence emission was observed also for mixtures of QBAs with 
GQ. However, the intercalation mechanism does not seem a very plausible possibility, as pointed out by CD 
measurements, because of insufficient space for the ligands between tetrads of GQ which, moreover, are probably 
occupied by cations45, 46. In this sense, the stoichiometries determined in this work are far from the 1:1 (GQ:QBA) 
stoichiometry described by Bhadra47 for sanguinarine, coralyne, palmatine and berberine with 5’-AG3(T2AG3)3-3’. 
However, it should be taken into account that the experimental conditions were different, and these could not only 
affect to the GQ structure (which was an hybrid parallel/antiparallel in that work) but also to the presence of 
additional interactions.  
Xiong et al.48 described three possible binding modes of heterocyclic alkaloids: stacking on the top or bottom G-
quartets, groove binding and loop binding. Although it is not possible to assign exact binding mode of interaction 
from spectroscopic experiments, it seems that there exist ~3 binding sites occupied by molecules of QBA with similar 
energetic level42, 49. Enhancement of fluorescence at 620 nm (like intercalation) would be explained by stacking (π-π 
stacking interaction) of QBA to structure of GQ resulting in low fluorescence quenching by water molecules or other 
quenchers present in solvent. The stacking interaction is also reported by other authors50, 51 and it is in agreement 
with observation provided by Shu et al.42 and Bhadra et al.47 for sanguinarine. 
Interaction of chelerythrine with GG21-T12T21 sequence and of sanguilutine and 
chelerythrine with Pu22-T14T23 sequence 
NMR experiments were used to study the mode of binding of these alkaloids with the G-quadruplex structures. 
The addition of chelerythrine to c-kit21T12T21 solution even at low ratio R=[ligand]/[DNA]=0.5/1.0 produced an 
upfield shift and a generalized broadening of H1 imino protons. The signals remain broad till the ratio R=3.0 was 
reached and a precipitate is formed (Figure 5). The assignment of the protons involved in the tetrads for the 
complexes and for the free nucleotides was performed by a combined used of a) the inter-residue NOE interactions 
between H1 imino protons (Table S5), b) the titration experiments and c) the inter-residue NOE connectivities 
between the H1 imino and aromatic H8 of guanine residues.  
A large change in the chemical shifts of the H1 imino protons (Δδ ≥0.80 ppm) was observed both for the H1 imino 
protons belonging to outer G-tetrads and for the internal one (Δδ ≥0.40 ppm) (Table 2). Several NOE contacts were 
found: the aromatic proton H6 of chelerythrine with H1 imino protons of G18, G7 and G19, the NCH3 protons with 
G20, and the 8-ethylene-dioxy with G18, suggesting strong interactions of chelerythrine with the oligonucleotide 
(Table 4). The generalized line broadening of all the signals and the presence of the NOE interactions either with the 
external and internal tetrads suggest the presence of multiple species in solution with the ligand positioned in 
different binding sites in chemical exchange. Also, the protons of the chelerythrine in the complex are broad, 
indicating a certain mobility inside the binding sites. 
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To better clarify the mode of binding of these alkaloids with the parallel G-quadruplex structure and to extend our 
investigation to the sequence responsible for the c-myc transcription activity we performed the NMR experiments 
with the Pu22-T14T23 sequence.  
The titration with chelerythrine and sanguilutine induced, even at low R=[ligand]/[DNA] ratio, a broadening of all the 
signals of DNA and of the ligand. At R ≥ 1.5 a new set of imino protons signals appeared at up-field shift, and the 
signals sharpened at R=2.0 (Figure 6). This suggested the formation of a defined complex with two ligand molecules 
interacting with the GQ structure. A further addition of ligands to Pu22-T14T23 caused only small changes in the H1 
imino protons until the R = 3.0 was reached.  
The analysis of the spectra at R=3.0 was performed starting from the attribution of the three tetrads by inter-residue 
NOE connectivities between the H1 imino and the aromatic protons H8 of guanine residues (following the procedure 
used for the study of other ligands.28, 52 The results reported in Table S6 show that the quadruplex structure is 
conserved. Also, for these complexes a significant shielding was observed for the H1 imino protons of the internal 
tetrad (δ = -0.30/-0.60 ppm) although lower than the values of the external tetrads (δ ≥- 0.60 ppm). In particular, 
it is relevant the δ =-1.36 ppm observed for the G16H1 of the chelerythrine complex (Tables S1 and S2).  
Sanguilutine showed NOE contacts of H6 with G22 H1. Other NOEs were found between some aromatic protons and 
H1 imino protons of G9, G18 and G22 belonging to the 3’-end tetrad. The methyl signal confirms the contacts to all 
these units and to G11 H1 belonging to the 5’-end tetrad. Due to the low solubility of the sanguilutine, the 
identification of all the aromatic protons of the ligand was difficult. The NMR spectra of chelerythrine complex 
instead are of better quality and all the proton signals of the ligand were identified. NOEs were found between the 
N-methyl and the aromatic protons H4 and H6 of the ligand with the H1 imino protons of G7, G11 and G16 units at 
5’-end. The same protons of the ligand also show NOE contacts with units at 3’-end, i.e. G9, G22, G18 and/or G13 
(Table 5) (figure 7). These results gave evidence of the location of chelerythrine over both the outer G-quartets. 
DOSY experiment, performed on the complex with chelerythrine, showed a diffusion coefficient indicating that the 
stoichiometry of the complex may be more than two ligands for G-quadruplex and excludes a higher aggregation of 
the nucleotide. The significant upfield chemical shifts of the imino protons belonging to the internal tetrad are 
difficult to be explained but they can suggest an interaction also at the level of this tetrad. 
Conclusions 
The interaction between human telomeric DNA (HT22) and modified c-kit structure (ckit21T21) and six plant 
benzo[c]phenanthridine alkaloids were studied by various spectroscopic techniques. Although these alkaloids have 
similar structure, they exhibit different contribution to stabilization of G-quadruplex structures as demonstrated 
with melting experiments. The ligands that mostly shift the Tm of HT22 are those showing an H atom at R5 position, 
and –O-CH2-O- group between R1 and R2. Sanguinarine and chelerythrine were found to be good stabilizers of both 
anti-parallel and parallel structures as those present in the segment of human telomeric and in the modified 21-mer 
of c-kit2 sequences. Alkaloid chelirubine was found to be excellent stabilizer of parallel GQ structure ckit21T21. 
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The NOESY experiments, performed with c-kit21T12T21 and Pu22T14T23 sequences, show that sanguilutine and 
chelerythrine have NOEs contacts with units at 3’and 5’ end, with two molecules being located respectively over the 
outer tetrads. 
The possibility that the ligand molecules may interact also at the level of the internal tetrad is suggested by the 
strong shelding of the imino protons signals of these units. This appears more probable for the complex with 
ckit21T21 sequence, where the ligand positioned in different binding sites appears in chemical exchange. 
Also, other studied alkaloids, except macarpine, have shown strong stabilizing effect, forming 1:3 or 1:4 complexes 
with GQ. These compounds seem to be potential selective GQ ligands as they practically do not stabilize the B-DNA 
duplex structure.  
Overall, these results suggest the potential use of these minor, non-commercial QBAs as G-quadruplex stabilizers in 
vivo, or for the development of analytical methods based on fluorescence spectroscopy. 
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Figure and table legends 
Table 1. DNA sequences used in this work.  
 
Code Sequence (5’ → 3’) Proposed structure 
HT22 A(GGGTTA)3GGG Antiparallel G-quadruplex 
ckit21T21 CGGGCGGGCGCGAGGGAGGGT Parallel G-quadruplex 
ckit21T12T21 CGGGCGGGCGCTAGGGAGGGT Parallel G-quadruplex 
Pu22-T14T23 TGAGGGTGGGTAGGGTGGGTAA Parallel G-quadruplex 
T20 T20 Unfolded strand 
ds26 CAATCGGATCGAATTCGATCCGATTG Duplex hairpin 
Dickerson CGCGAATTCGCG Duplex 
bcl-2 CGGGCGCGGGAGGAAGGGGGCGGG Hybrid G-quadruplex 





























Table 2. 1 H chemical shift values for the complex of chelerythrine with c-kit21T12T21.a 
 
 H1/H2/H5/CH3 Δδb H6/H8 Δδb 
C1 6.08 +0.53 7.55 +0.05 
G2 11.15 -0.81 8.03 -0.17 
G3 10.88 -0.42 7.69 -0.09 
G4 10.42 -0.73 7.70 -0.05 
C5 6.22 +0.02 7.81 -0.23 
G6 n.d. - n.d. - 
G7 11.07 -0.51 7.84 -0.18 
G8 10.48 -0.83 7.76 -0.03 
C9 6.20 +0.10 7.62 0.00 
G10 n.d. - 8.03 +0.04 
C11 6.10 +0.04 7.94 +0.04 
T12 1.88 -0.02 7.50 -0.10 
A13 n.d. - 8.28 +0.18 
G14 11.10 -0.84 n.d. - 
G15 10.78 -0.40 7.68 -0.19 
G16 10.25 -0.79 7.69 -0.09 
A17 n.d. - 8.56 +0.03 
G18 10.69 -1.13 n.d. - 
G19 11.02 -0.50 7.77 -0.32 
G20 10.45 -0.80 7.73 +0.03 
T21 n.d. - n.d.     - 
 
a Measured at 25°C in ppm (δ) from external DSS. Solvent H2O-D2O (90:10 v/v), 5 mM phosphate buffer, 20 mM KCl, pH 6.9, R = 





Table 3. GQ stabilization by QBAs in melting and binding experiments. The experimental conditions of melting 
studies were 2 µM GQ, 4 µM QBA, 10 mM phosphate buffer, 5 mM KCl, pH 7.0. In the case of binding studies, the 
experimental conditions were 3 µM QBA, 10 mM phosphate buffer, 5 mM KCl, pH 7.0, 25 oC. GQ concentration 
varied from 0 to 10 M. Tm values were determined from two replicates. In all cases, incertitude values are below 1 
oC. Figures written in italics are only estimated values because of high experimental error.  
 
GQ QBA Tm [°C] Tm [°C] Proposed 
stoichiometry 
Logarithm of overall formation constant β 
(standard deviation) 
HT22 no alkaloid 51.0 - - - 
 Macarpine (MA) 50.1 -0.9 1:5 31.3 (0.1) 
 Chelirubine (CHR) 64.6 13.6 1:4 24.5 (0.2) 
 Sanguinarine (SG) 69.1 18.1 1:3 ~ 16 
 Chelerythrine (CHE) 63.3 12.3 1:3 17.1 (0.1) 
 Sanguirubine (SR) 62.2 11.2 1:3 19.3 (0.1) 
 Sanguilutine (SL) 57.6 6.6 1:3 19.1 (0.1) 
ckit21T21 no alkaloid 50.0 - - - 
 Macarpine (MA) 56.3 6.3 1:3 17.6 (0.1) 
 Chelirubine (CHR) 74.5 24.5 1:3 17.3 (0.1) 
 Sanguinarine (SG) 65.5 15.5 1:4 ~ 22 
 Chelerythrine (CHE) 70.7 20.7 1:3 ~ 15 
 Sanguirubine (SR) 70.8 20.8 1:4 23.9 (0.1) 








Table 4. Inter-molecular NOE in the complex of chelerythrine with c-kit21T12T21. Experimental data acquired at 












Table 5. Inter-molecular NOE in the complex of chelerythrine with Pu22-T14T23. Experimental data acquired at 25°C 

















a The two signals are overlapped   


















Figure 1. General structure of QBAs and G-quadruplex. (a) General formula of QBAs and acid-base equilibria. (b) 
Nomenclature and substitutions of the QBAs studied in this work. (c) Planar arrangement of four guanine bases in a 








Figure 2. Melting experiments. (a) Normalized melting curves of ckit21T21 (black) with macarpine (blue), 
chelerythrine (violet), sanguirubine (yellow), sanguinarine (orange), sanguiltuine (green) and chelirubine (red). (b) 
Normalized melting curves of (GC)6 dsDNA (black) with macarpine (blue) and chelirubine (red). In all cases, CDNA = 2 








Figure 3. Competitive dialysis assays. Fluorescence intensities of alkaloids with DNA structures. Experimental 
































































Figure 4. Spectrofluorimetrically-monitored binding studies. (a) Fluorescence spectra recorded along the titration of 
macarpine: spectrum of macarpine at concentration of 3 µM (blue dots) and macarpine with HT22 at concentration 
of 20 µM concentration (red crosses). Other experimental conditions were 10 mM phosphate buffer, 5 mM KCl, 25 
oC. (b) original fluorescence signal at 600 nm for the titration of macarpine at different concentration of HT22 
(triangles), fluorescence signal of macarpine with oligonucleotide (A)12 representing non-specific interaction 























Figure 5. Imino proton region of the 1D NMR titration spectra of c-kit21T12T21 with chelerythrine. Experimental 






Figure 6. Imino proton region of the 1D NMR titration spectra of Pu22-T14T23 with (a) sanguilutine and (b) 














Figure 7. Expanded region of the 2D NOESY spectrum of Pu22-T14T23 / cheleryhthrine complex showing in the 
boxes: (a) the sequential NOE interactions between the H1 imino protons; (b) and (c) some NOE interactions 
between the aromatic proton H6 and NCH3 of chelerythrine and the nucleotide. Experimental conditions are detailed 
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